MarketsandMarkets

Real-World Evidence and Data Analytics Conference

5th - 6th October 2023

Frankfurt, Germany

Revolutionizing Healthcare with RWD / RWE to Accelerate Regulatory Decision Making

Real-world data and real-world evidence are poised to keep making strides in 2023. This analysis of clinical evidence studies the usage, potential advantages and risk of a medical product inferred from the real-world data analysis. Real-world evidence (RWE) is accelerating its involvement in the early benefit elucidation of medicinal drugs.

RWE solutions have proven to be extremely useful, as they allow industrial and academic researchers to monitor patients using digitally connected platforms while assisting to organize and evaluate clinical data for regulatory submissions. Since RWE research is still in an evolution process, and few gaps in the area have been explored, more guidance and a consented annotation is obligatory to increase the effectuation of real-world data.

After five successful editions of Real-World Evidence and Life Sciences Analytics Conference in Boston, USA, MarketsandMarkets is proud to announce its upcoming Europe edition of Real-World Evidence and Life Sciences Analytics Conference to be held on October 5th- 6th 2023 in Frankfurt, Germany. The conference will bring the full spectrum of experts, leaders, and stakeholders to share a board prospective on significant points and hold discussions on the best practices with a key takeaway being better decision making.

WHAT TO EXPECT

  • Regulatory view around data quality & data standards.
  • Leveraging RWE for improving market access.
  • The adoption & role of AI & ML in clinical trials.
  • Real-world evidence & Digital Health - The expanded role of RWE for digital health.
  • Real-World Data & Advanced Analytics.
  • RWE to inform decision making process in rare diseases where there is lack of evidence.

  • Learn about the recent trends and advancements in Real-World Evidence Generation 
  • Engage in meaningful discussion with the most prominent industry experts and decision makers from pharmaceutical and biopharmaceutical companies who will address most critical challenges in real-world data and real-world evidence space. 
  • Opportunity to network and exchange scientific knowledge with expert speakers from leading pharmaceutical companies, global regulators and solution providers

From Pharmaceutical and Biopharmaceutical companies

Chief executives, VP’s, Directors, Global heads, Heads, Leaders, Senior Managers, Researcher, Analysts, Investigators, Scientists within the following departments-

  • Real-World Evidence
  • Real-World Data
  • Data Analytics
  • Health Economics & Outcomes Research- HEOR
  • Market Access/Value Access
  • Policy
  • Clinical Development & research
  • Clinical trial
  • Centre for Observational and Real-World Evidence
  • Epidemiology
  • Oncology-RWE
  • Pricing and Reimbursement
  • Medical Affairs
  • Pharmacovigilance
  • Life Science Analytics
  • Big data
  • Data Science
  • Bio-Statistics
  • Consumer Healthcare

CONFERENCE AGENDA

Registration

08:15 - 08:50

Welcome note by MarketsandMarkets

08:50 - 08:55

Opening remarks by the Chairperson

08:55 - 09:00

Keynote- Real World Data – To Drive Integrated Evidence Generation

09:00 - 09:30

Maximizing the influence of RWD in cases of Rare Diseases

09:30 - 10:00

Solution Provider Presentation

10:00 - 10:30

Morning Refreshments and Poster Presentation | One-to-One Networking Meeting

10:30 - 11:20

Role of Data Quality in advancing the use of RWE for Regulatory Decision Making

11:20 - 11:50

Application of RWD/RWE in Strategy Framework and Regulatory Considerations

11:50 - 12:20

Solution Providers Presentation

12:20 - 12:50

Panel Discussion – Creating Value from Next Generation RWE

12:50 - 13:20

Lunch and Poster Presentation | One-to-One Networking

13:20 - 14:20

Research and Related Initiatives to Evaluate and Improve RWD for Evidence Generation

14:20 - 14:50

RWD in Drug Development Program

14:50 - 15:20

Solution Providers Presentation

15:20 - 15:50

Evening Refreshments and Poster Presentation | One-to-One Networking

15:50 - 16:30

Current Trends in Patient-Centric Clinical Research amid the Rapidly evolving Landscape

16:30 - 17:00

Patient Engagement Strategy and Execution

17:00 - 17:30

Achieving Patient Diversity using RWE in Clinical Trials

17:30 - 18:00

Closing remarks by the Chairperson

18:00 - 18:00

End of Day 1

18:00 - 18:00

Registration

08:15 - 08:50

Welcome note by MarketsandMarkets

08:50 - 08:55

Opening remarks by the Chairperson

08:55 - 09:00

RWE- Trends in Global Market and Network Access

09:00 - 09:30

Patient Access to Precision Medicine Oncology

09:30 - 10:00

Solution Providers Presentation

10:00 - 10:30

Morning Refreshments and Poster Presentation | One-to-One Networking

10:30 - 11:15

Obtain Insight into HEOR Complexities, Parameters and Opportunities

11:15 - 11:45

Solution Providers Presentation

11:45 - 12:15

Global Landscape around Real- World Evidence

12:15 - 12:45

Panel Discussion - Patient Engagement Strategy and Execution

12:45 - 13:15

Lunch and Poster Presentation | One-to-One Networking

13:15 - 14:15

Pricing Market Access Strategies Case Studies

14:15 - 14:45

Assessing Patient centered approach to value-based approach

14:45 - 15:15

Closing remarks by the chairperson

15:15 - 15:15

End of Conference

15:15 - 15:15

ENQUIRE NOW

CONFERENCE SPEAKERS

ADVISORS

Helene Vioix

Helene Vioix

Director Global Evidence & Value Development Oncology, Merck KGaA

SPEAKERS

Helene Vioix

Helene Vioix

Director Global Evidence & Value Development Oncology, Merck KGaA

Antje Hottgenroth

Antje Hottgenroth

Associate Director, Real World Data Europe/ International Value, Evidence, and Outcomes (VEO) - Center of Innovation, Lilly Deutschland GmbH

Ahmed H. Seddik

Ahmed H. Seddik

Senior Manager, Global HEOR & RWE, Oncology, Daiichi Sankyo Europe GmbH

SPONSORS

Cegedim

LOCATION

Venue

Frankfurt, Germany

PAST EVENT GALLERY